Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Differences in deoxyadenosine metabolism in human and mouse lymphocytes.

× No keyword cloud information.

11 in total

1. The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency.

Authors: W R Osborne; C R Scott
Journal: Biochem J Date: 1983-09-15 Impact factor: 3.857

2. Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.

Authors: R F Kefford; R M Fox
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

3. Further differentiation of murine double-positive thymocytes is inhibited in adenosine deaminase-deficient murine fetal thymic organ culture.

Authors: C Justin Van De Wiele; Michelle L Joachims; Amy M Fesler; James G Vaughn; Michael R Blackburn; Stephanie T McGee; Linda F Thompson
Journal: J Immunol Date: 2006-05-15 Impact factor: 5.422

4. Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation.

Authors: C Justin Van De Wiele; James G Vaughn; Michael R Blackburn; Catherine A Ledent; Marlene Jacobson; Hong Jiang; Linda F Thompson
Journal: J Clin Invest Date: 2002-08 Impact factor: 14.808

5. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.

Authors: D A Carson; D B Wasson; J Kaye; B Ullman; D W Martin; R K Robins; J A Montgomery
Journal: Proc Natl Acad Sci U S A Date: 1980-11 Impact factor: 11.205

6. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.

Authors: D A Carson; D B Wasson; L M Esparza; C J Carrera; T J Kipps; H B Cottam
Journal: Proc Natl Acad Sci U S A Date: 1992-04-01 Impact factor: 11.205

7. Development and maintenance of bovine cytotoxic lymphocytes with recombinant human interleukin-2.

Authors: J Carter; N S Magnuson; W C Davis; P H Mason; J A Magnuson; J E Talmadge; P J Barr
Journal: Immunology Date: 1986-01 Impact factor: 7.397

8. Restoration of adenosine deaminase-deficient human thymocyte development in vitro by inhibition of deoxynucleoside kinases.

Authors: Michelle L Joachims; Patrick A Marble; Aletha B Laurent; Peter Pastuszko; Marco Paliotta; Michael R Blackburn; Linda F Thompson
Journal: J Immunol Date: 2008-12-01 Impact factor: 5.422

9. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice.

Authors: M Wakamiya; M R Blackburn; R Jurecic; M J McArthur; R S Geske; J Cartwright; K Mitani; S Vaishnav; J W Belmont; R E Kellems
Journal: Proc Natl Acad Sci U S A Date: 1995-04-25 Impact factor: 11.205

10. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.

Authors: D A Carson; D B Wasson; E Lakow; N Kamatani
Journal: Proc Natl Acad Sci U S A Date: 1982-06 Impact factor: 11.205